Search results
Jim Cramer’s Latest Stock Picks in May 2024
Insider Monkey via Yahoo Finance· 4 days agoJim Cramer on Friday analyzed the market rally following the latest CPI data which showed inflation was easing in April. Cramer said bears are clearly...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 2 days agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
Philippe Laffont's Strategic Moves in Q1 2024: A Deep Dive into
Guru Focus· 6 days agoInsights into Coatue Management's Latest 13F Filing Philippe Laffont (Trades, Portfolio), the founder of Coatue Management, has made notable adjustments to his
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 7 days agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -4.30%) stock has...
Philippe Laffont's Strategic Moves in Q1 2024: A Deep Dive into NVIDIA's Significant Reduction
GuruFocus.com via Yahoo Finance· 6 days agoModerna Inc (NASDAQ:MRNA), liquidating all 3,273,052 shares, with a -1.37% portfolio impact. Key...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 4 days ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 5 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 1 day agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly - Altimmune (NASDAQ:ALT), Amgen...
Benzinga· 4 days agoThe obesity market has garnered much interest lately, ever since Novo Nordisk NVO received FDA...